Jim Cramer’s top 10 things to watch in the stock market Tuesday

1. The outgoing Biden administration proposed a rule that would expand access to obesity drugs for millions of Americans enrolled in Medicare and Medicaid. If implemented, that would be great news for Eli Lilly, a longtime Club name we bought more of on Monday. Shares of Lilly and chief rival Novo Nordisk were higher on the news.

2. Amgen shares tumbled more than 11% after its weight-loss treatment helped patients lose up to 20% of their body weight on average over 12 months. Investors had high hopes for the drug, known as MariTide. It may not be as effective as Lilly’s and incidences of sickness look worse than Lilly’s.

3. President-elect Donald Trump pledged to impose a 25% tariff on imports from Mexico and Canada, along with an additional 10% levy on goods from China, upon taking office in January. Notable that Trump’s threats on Mexico and Canada are bigger than China, although there are higher tariffs on Chinese goods left over from his first term. Are we going soft on China? Could be negotiating.